Suchita Chaudhari is an accomplished strategic leader with more than a decade of experience in pricing, reimbursement, and market access. Her proficiency in representing the payer's voice across the drug development process has culminated in evidence-backed "Value for Money" payer communication materials, including global value dossiers, payer materials, and global strategic guidance playbooks. She has significant experience working in bone health, hepatology, immunology, infectious diseases, neurology, ophthalmology, and respiratory, among other therapeutic areas. Her efficient project and team management skills enabled her to deliver projects within tight deadlines through effective planning and communication with business stakeholders. Suchita has collaborative and empathetic yet assertive nature, which helps her develop solutions and negotiate consensus-driven outcomes.

Suchita Chaudhari holds a B.Sc. from Stella Maris College affiliated to the University of Madras, an MBA, and an M.Sc. from the Indian Institute of Technology, Madras. She served as Senior Director (Access, Reimbursement and Pricing Lead-setrusumab) at Mereo BioPharma, Global Pricing & Payer Value Strategy Director (Bone Health and Rare Disease) at UCB, and Associate Director-Liver Diseases and Inflammation (EMEA - Market Access) at Gilead Sciences. She has also held several senior-level positions in prestigious organizations such as GSK, PAREXEL International, IMS Consulting Group, Frost & Sullivan, and ValueNotes Database Pvt. Ltd.